GGrantIndex
Sort

51,593 grants matching hepatitis

Phenotyping Genetic Disorders of Hepatic Lipid and Lipoprotein Metabolism in Cells, Mice, and Men

$953,882
Henry N Ginsberg · Columbia University Health Sciences · R35 · FY2022 · HL

Adenovirus Protease Regulation and Antiviral Development

$953,757
Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2003 · AI

AIDS International Training and Research Program

$953,630
Carey Farquhar · University Of Washington · D43 · FY2007 · TW

Human Polycystic Kidney Disease

$953,461
University Of Colorado Denver · P01 · FY2002 · DK

RECURRENT HEPATITIS B AFTER LIVER TRANSPLANTATION

$953,315
University Of Michigan At Ann Arbor · U01 · FY2004 · DK

Subclinical Vascular Disease and Metabolic Abnormalities in MACS

$953,021
Wendy S Post · Johns Hopkins University · R01 · FY2012 · HL

The role of cancer stem cells in liver cancer heterogeneity and subtypes

$952,089
Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Molecular signatures for liver cancer diagnosis and treatment stratification

$952,089
Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Xenobiotic Metabolism

$952,015
Leo T Burka · Environmental Health Sciences · Z01 · FY2007 · ES

Molecular Basis of Cancer Virus Replication, Transformation, and Innate Defense

$951,305
Daniel Dimaio · Yale University · P01 · FY2019 · CA

Novel agents for mitigation of radiation-induced pulmonary injury

$950,371
Kathryn Dale Held · Massachusetts General Hospital · RC1 · FY2009 · AI

Immune Control and Evasion During Acute HCV Infection

$950,277
Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2009 · AI

Human Dendritic Cell Subsets

$950,220
Jacques F Banchereau · Baylor Research Institute · U19 · FY2008 · AI

HBI-002 to Treat Diabetic Retinopathy

$950,200
Edward Gomperts · Hillhurst Biopharmaceuticals, Inc. · R44 · FY2024 · EY

Subclinical Vascular Disease and Metabolic Abnormalities in MACS

$950,109
Wendy S Post · Johns Hopkins University · R01 · FY2010 · HL

Clinical Trials Network, Ohio Valley Node

$950,000
Eugene C. Somoza · University Of Cincinnati · U10 · FY2007 · DA

Task D06: Woodchuck Animal Model for Testing HBV Therapeutics

$949,703
Georgetown University · N01 · FY2012 · AI

Intracellular Signaling In Endocrine Cells

$949,242
Stanko S. Stojilkovic · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD

The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network

$948,855
Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2018 · DA

HCV Replication and Immunity

$948,736
Research Inst Nationwide Children'S Hosp · U19 · FY2005 · AI

Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)

$948,453
David W Crabb · Indiana University Indianapolis · U01 · FY2012 · AA

Western States Node of the National Drug Abuse Treatment Clinical Trials Network

$948,068
James L. Sorensen · University Of California, San Francisco · UG1 · FY2018 · DA

Molecular Mechanisms of TGF-beta Signaling Pathway

$947,986
Ying Zhang · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Inhibitors and Probes of HIV-1 Cell Fusion

$947,627
Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK

Enveloped Virus Glycoprotein/receptor Interactions

$947,359
Edward Berger · Niaid Extramural Activities · Z01 · FY2007 · AI